AstraZeneca

In collaboration with academia and industry partners, we are delighted to share our latest article, published in Nature Reviews Drug Discovery. This insightful analysis explores pivotal shifts from the last two decades in key physicochemical properties and optimization strategies in the development of innovative drug candidates, and where the future is headed. Read more: https://learn.az/60474NuoH #WhatScienceCanDo #MedicinalChemistry

Since 2010, the Young Health Programme (YHP) has empowered young people to make healthier choices and champion health equity. 🌍💙 Our partnership with One Young World has strengthened this mission, uniting youth health leaders worldwide. Check out the latest report highlighting the incredible impact of 17 YHP Impact Fellows across 13 countries, who were supported by the YHP with a fully funded scholarship to attend the One Young World Summit and grants to further their work through their not-for-profit organisations. Learn more ➡️ https://learn.az/60474fz7S #YoungHealthProgramme

Uncontrolled or treatment-resistant hypertension continues to affect millions globally. Elevated blood pressure increases the risk of serious complications, yet advancements in treatment options have remained limited for two decades. We are focused on advancing research to better understand the challenges for hypertension that is hard to control. Discover more about our work in this area. https://learn.az/60414N30W

Partnering with The University of Sheffield, we are advancing a cutting-edge, AI-driven approach to enhance a key protein engineering process essential to our biologics discovery efforts. Read more: https://learn.az/60474qBIU #AIinBiologics #AIinRDPublicationSpotlight

This week in Osaka, Japan we joined leaders from government, healthcare and academia for the Partnership for Health System Sustainability and Resilience (PHSSR) Summit at #EXPO2025. We’ve had critical discussions on how to: 🩺 Strengthen preventative healthcare and enable earlier intervention on disease to reduce health inequities 💻 Accelerate digital transformation to improve efficiencies and close healthcare gaps ⬆️ Improve sustainable healthcare financing to support population and societal health Public-private partnerships play a vital role in improving healthcare delivery – now and in the future. 🔗 Learn more: https://learn.az/60434lOQ3 #PHSSR #Sustainability #HealthEquity #NCDs

This week we were recognised by BritishAmerican Business (BAB) at the 2025 Transatlantic Growth Awards for our $3.5 billion investment in the United States. This reflects our commitment to strengthening transatlantic collaboration in life sciences by advancing research and manufacturing capabilities across key locations and building stronger global partnerships. #WhatScienceCanDo

#News 📢 We're further strengthening our global footprint with the expansion of our state-of-the-art Global Hub in Bangalore, creating 400 Jobs to boost R&D, Global Business Services and AI innovation. This facility will play a vital role in accelerating the development of innovative medicines through automated, scalable, and data-driven solutions across R&D—ultimately benefitting patients around the world. #WhatScienceCanDo

We’re named among the top 20 World’s Most Sustainable Companies by TIME Magazine! Based on an assessment of more than 5,700 companies, this recognition reflects our dedication to driving sustainable impact across our value chain – from action on climate and nature, to health equity and health systems resilience. Thank you to all our people and partners for pushing the boundaries of what science can do for a healthier future for people, society and the planet 🌍 Read more and get the full list: https://learn.az/60494jRuW #WhatSienceCanDo #Sustainability #TIME #WorldsMostSustainableCompanies #LCAW2025

Our teams partnered with the University of Cambridge Department of Computer Science and Technology to develop a new AI-driven method for drug discovery that has been published in Nature Communications. The model helps researchers better predict how molecules may interact with the body and identify those most likely to succeed in further development. Accelerating early-stage research brings us closer to our goal of delivering innovative medicines faster to patients. We’re especially proud that early-career researchers played a leading role in this work, a great example of how collaboration not only drives innovation but also helps shape the future of science. Learn more here: https://learn.az/60404XDw4 #AIinDrugDiscovery #AIinRDPublicationSpotlight

We're honoured to be recognized in the Gartner for Supply Chain Top 25 for the fourth consecutive year. This cross-industry ranking reflects our focus on bringing medicines to patients faster—and more sustainably—than ever before. Thank you to Gartner, our peers and our teams globally for their agility and commitment to excellence. #GartnerTop25 #SCExcellence